|
시장보고서
상품코드
2082466
콜라겐 시장 : 콜라겐 유형, 원료, 형태, 추출 프로세스, 등급, 용도, 판매 채널별 - 세계 시장 예측(2026-2032년)Collagen Market by Collagen Type, Source, Form, Extraction Process, Grade, Application, Sales Channel - Global Forecast 2026-2032 |
||||||
360iResearch
콜라겐 시장은 2032년까지 연평균 복합 성장률(CAGR) 8.47%로 성장해 97억 5,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 55억 2,000만 달러 |
| 추정 연도(2026년) | 59억 7,000만 달러 |
| 예측 연도(2032년) | 97억 5,000만 달러 |
| CAGR(%) | 8.47% |
콜라겐은 체내에서 가장 풍부하게 존재하는 구조 단백질로, 인체의 총 단백질 중 약 30%를 차지합니다. 따라서 피부의 탄력, 뼈의 강도, 연골의 건강, 상처 치유, 결합 조직의 기능에 있어 매우 중요한 역할을 합니다. 상업용 분야에서는 콜라겐이 가수분해 콜라겐 펩타이드, 젤라틴, 천연 콜라겐, 의료용 콜라겐의 형태로 영양보조식품, 기능성 식품, 화장품, 의약품, 상처 관리, 생체 재료 부문에서 널리 활용되고 있습니다.
콜라겐 시장 동향은 범용 젤라틴이나 기본적인 건강기능식품에서 임상적 근거에 기반하여 용도에 특화된 프리미엄 원료로 전환되고 있습니다. 각 브랜드는 단순히 '미용'이나 '관절 건강'과 같은 광범위한 메시지에 의존하기보다는 분자량, 원료의 추적 가능성, 펩타이드 프로파일, 생체 이용률, 관능적 특성, 과학적 근거에 기반한 효능 표기를 통해 제품의 차별화를 꾀하고 있습니다.
인공지능(AI)은 콜라겐의 발견, 제조, 품질 보증, 상품화의 전 단계에 걸쳐 점차적인 영향력을 행사하고 있습니다. AI를 활용한 단백질 모델링, 펩타이드 스크리닝, 제형 최적화를 통해 용해성, 맛의 마스킹, 피부 보습, 연골 지원과 같은 목표 성과에 부합하는 콜라겐 펩타이드 서열, 부형제의 조합, 투여 형태를 특정함으로써 개발 주기를 단축할 수 있습니다.
아시아태평양은 방대한 소비자 인구, 미용 및 웰니스 문화의 정착, 전자상거래의 확대, 그리고 일본, 한국, 중국, 호주, 동남아시아에서의 해양성 콜라겐 수요 증가에 힘입어 콜라겐 시장의 주요 성장 동력이 되고 있습니다. 북미는 성숙한 건강기능식품 유통 채널, 스포츠 영양 제품의 보급, 메디컬 에스테틱에 대한 수요, 기능성 식품의 혁신이 충분히 진전된 데 힘입어 계속해서 고부가가치 지역으로 자리매김하고 있습니다. 특히, 소비자들이 건강한 노화, 관절 유연성, 피부 관리 등을 목적으로 콜라겐 펩타이드를 찾는 경향이 강해지고 있습니다.
아세안 시장에서는 젊은 층의 디지털 소비자, ‘내면에서 아름다움을 가꾸는’ 트렌드, 크로스보더 전자상거래가 호재로 작용하면서, 합리적인 가격의 콜라겐 파우더, 음료, 캡슐, 구미에 대한 수요가 생겨나고 있습니다. GCC 지역은 할랄 인증을 받은 콜라겐, 프리미엄 뉴트라슈티컬, 클리닉 주도의 웰니스 제품에 있어 전략적으로 중요한 시장입니다. 특히, 소비자들이 피부과, 미용, 예방 의료, 종교적 규범에 부합하는 원료 조달을 중요하게 여기는 지역에서 그 중요성은 더욱 커지고 있습니다.
미국은 건강기능식품, 스포츠 영양제, 기능성 음료, 메디컬 에스테틱, 상처 관리 분야를 통해 고부가가치 콜라겐 수요를 주도하고 있습니다. 한편, 캐나다에서는 클린 라벨 웰니스 제품 및 자연 건강 제품과 관련된 꾸준한 수요가 나타나고 있습니다. 멕시코와 브라질은 라틴아메리카의 주요 시장이며, 미용, 헤어 케어, 네일 케어, 관절 건강과 같은 마케팅 메시지가 일반 소비자와 프리미엄 고객층 모두에게 큰 호응을 얻고 있습니다. 이는 예방적 웰니스에 대한 관심이 높아지고, 간편한 형태의 건강기능식품에 대한 수요가 확대되고 있는 데 힘입은 것입니다.
소비자들이 안전성, 유효성, 지속가능성, 원산지를 점점 더 엄격하게 따져보는 시장에서 업계 리더는 신뢰를 강화하기 위해 조달처의 투명성, 제3자 기관의 검사, 임상적 근거를 우선시해야 합니다. 기업은 제품의 효능 표기를 현지 규정에 부합하도록 하고, 피부 보습, 탄력, 관절의 편안함, 가동성 등 검증된 평가 지표에 투자하며, 인체를 대상으로 한 근거로 뒷받침되지 않는 광범위한 효능 표기는 피해야 합니다.
본 요약 보고서는 공개 정보, 규제 정보, 과학 정보 및 산업 관련 정보원을 활용한 체계적인 2차 조사 접근 방식을 바탕으로 작성되었습니다. 주요 정보 출처로는 세계보건기구(WHO)와 유엔(UN)의 인구 통계 데이터, FAO 관련 자료에서 얻은 식품 및 농업 관련 정보, 미국 FDA 및 유럽 당국 등의 규제 체계, 그리고 콜라겐 펩타이드, 젤라틴, 생체 재료, 기능성 성분에 관한 동료 심사를 거친 문헌이 포함됩니다.
콜라겐 시장은 과학 주도형이자 용도 특화형이며, 전 세계적으로 다양화된 산업으로 진화하고 있습니다. 고령화, 예방 의료에 대한 인식 제고, ‘내면에서 아름다움을 가꾸는’ 개념의 확산, 스포츠 영양 및 생물의학 분야의 혁신에 힘입어, 그 상업적 중요성은 기존 젤라틴이나 기본적인 건강기능식품으로서의 용도를 넘어 확대되고 있습니다.
The Collagen Market is projected to grow by USD 9.75 billion at a CAGR of 8.47% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 5.52 billion |
| Estimated Year [2026] | USD 5.97 billion |
| Forecast Year [2032] | USD 9.75 billion |
| CAGR (%) | 8.47% |
Collagen is the body's most abundant structural protein and accounts for roughly 30% of total human protein, making it central to skin elasticity, bone strength, cartilage integrity, wound healing, and connective tissue performance. In commercial applications, collagen is widely used as hydrolyzed collagen peptides, gelatin, native collagen, and medical-grade collagen across nutraceuticals, functional foods, cosmetics, pharmaceuticals, wound care, and biomedical materials.
Demand is being reinforced by measurable demographic and lifestyle shifts, including global population aging, higher consumer spending on preventive health, rising sports nutrition adoption, and increased clinical interest in joint, bone, and skin health. The World Health Organization projects that by 2030, one in six people globally will be aged 60 years or older, strengthening long-term demand for collagen supplements, regenerative medicine inputs, and healthy-aging formulations.
The collagen landscape is shifting from commodity gelatin and basic supplements toward premium, clinically positioned, application-specific ingredients. Brands are increasingly differentiating products by molecular weight, source traceability, peptide profile, bioavailability, sensory performance, and evidence-based claims rather than relying only on broad beauty or joint-health messaging.
Sourcing is also changing. Marine collagen is gaining visibility due to pescatarian compatibility and strong positioning in beauty-from-within products, while bovine, porcine, poultry, and eggshell membrane-derived collagen continue to serve cost-sensitive and high-volume applications. At the same time, fermentation-enabled and recombinant collagen technologies are attracting interest as manufacturers seek animal-free, controlled, and scalable alternatives that can reduce variability and address ethical, religious, and allergen-related concerns.
Artificial intelligence is becoming a cumulative force across collagen discovery, manufacturing, quality assurance, and commercialization. AI-enabled protein modeling, peptide screening, and formulation optimization can shorten development cycles by identifying collagen peptide sequences, excipient combinations, and delivery formats that align with targeted outcomes such as solubility, taste masking, skin hydration, or cartilage support.
In manufacturing and supply chains, machine learning improves yield forecasting, batch consistency, contaminant detection, and traceability. Computer vision and predictive analytics can help monitor raw material quality, while natural language processing supports regulatory intelligence by tracking claims, safety notices, and labeling requirements across jurisdictions. For industry leaders, AI is not replacing scientific validation; it is accelerating hypothesis generation, quality control, and evidence-based product positioning.
Asia-Pacific is a major growth engine for collagen due to large consumer populations, strong beauty and wellness cultures, expanding e-commerce, and rising demand for marine collagen in Japan, South Korea, China, Australia, and Southeast Asia. North America remains a high-value region supported by mature supplement channels, sports nutrition adoption, medical aesthetics demand, and well-developed functional food innovation, particularly as consumers seek collagen peptides for healthy aging, mobility, and skin support.
Europe is shaped by strict safety, traceability, and claims substantiation requirements, making regulatory discipline, documented quality, and responsible sourcing essential for collagen suppliers. Latin America is gaining momentum through beauty, hair, nail, and joint-health positioning, led by Brazil and Mexico, where wellness products are increasingly integrated into daily personal care routines. The Middle East is developing opportunities around halal-certified collagen, premium wellness, and medical tourism, while Africa remains an emerging market where affordability, distribution access, localized formats, and health education will influence adoption.
ASEAN markets are benefiting from young digital consumers, beauty-from-within trends, and cross-border e-commerce, creating demand for affordable collagen powders, drinks, capsules, and gummies. The GCC is strategically important for halal-certified collagen, premium nutraceuticals, and clinic-led wellness offerings, particularly where consumers place high value on dermatology, aesthetics, preventive health, and religiously compliant sourcing.
The European Union is a benchmark for food safety, traceability, and substantiated health claims, influencing global documentation standards for collagen brands. BRICS countries represent a scale opportunity because of large populations, expanding middle classes, rising healthcare awareness, and growing local manufacturing capacity. G7 markets remain innovation-led, with advanced regulatory systems, clinical research infrastructure, and premium consumer segments, while NATO economies overlap with many high-income healthcare and personal care markets that prioritize supply chain resilience, quality assurance, and trusted sourcing.
The United States leads high-value collagen demand through supplements, sports nutrition, functional beverages, medical aesthetics, and wound care applications, while Canada shows steady demand linked to clean-label wellness and natural health products. Mexico and Brazil are important Latin American markets where beauty, hair, nails, and joint-health positioning resonate strongly with mass and premium consumers, supported by growing interest in preventive wellness and accessible supplement formats.
In Europe, the United Kingdom, Germany, France, Italy, and Spain support demand through nutraceuticals, dermocosmetics, functional foods, and pharmaceutical-grade materials, while Russia remains influenced by local distribution dynamics, import access, and domestic retail conditions. China and India offer large-scale potential driven by rising incomes, e-commerce penetration, preventive health awareness, and expanding beauty and nutrition categories. Japan and South Korea are innovation leaders in beauty-from-within, functional foods, and advanced skincare nutrition, and Australia benefits from premium wellness positioning, strong marine-resource branding, and export-oriented nutraceutical expertise.
Industry leaders should prioritize source transparency, third-party testing, and clinical substantiation to strengthen trust in a market where consumers increasingly scrutinize safety, efficacy, sustainability, and origin. Companies should align product claims with local regulations, invest in validated endpoints such as skin hydration, elasticity, joint comfort, or mobility, and avoid broad claims that cannot be supported by human evidence.
Strategically, manufacturers should diversify raw material sourcing, evaluate marine and recombinant collagen opportunities, and build resilient supplier networks to mitigate disruptions. Brands should use AI-assisted consumer analytics to identify need states, optimize formats such as powders, ready-to-drink beverages, capsules, bars, and gummies, and personalize messaging by age group, lifestyle, dietary preference, and application.
The executive summary is based on a structured secondary research approach using public, regulatory, scientific, and industry-relevant sources. Key inputs include demographic data from the World Health Organization and United Nations, food and agriculture context from FAO-related resources, regulatory frameworks from agencies such as the U.S. FDA and European authorities, and peer-reviewed literature on collagen peptides, gelatin, biomaterials, and functional ingredients.
The analysis triangulates demand indicators across end-use sectors, regional consumption patterns, sourcing trends, regulatory conditions, and technology adoption. Interpretation emphasizes verified structural drivers rather than unsupported projections, ensuring that insights remain suitable for strategic planning, market education, and decision-making across the global collagen industry.
The collagen market is evolving into a science-led, application-specific, and globally diversified industry. Aging demographics, preventive health behavior, beauty-from-within adoption, sports nutrition, and biomedical innovation are expanding commercial relevance beyond traditional gelatin and basic supplement use.
Future competitiveness will depend on evidence, quality, traceability, regulatory discipline, and innovation in sustainable sourcing and AI-enabled development. Organizations that combine clinical credibility with consumer-centric formats and resilient supply chains will be best positioned to capture long-term value in the global collagen industry.